Current News

Molecular profiling and access to treatment for rare cancers in Europe - ARCAGEN study final results

July 23, 2026

New study advances personalised medicine for rare Peritoneal Mesothelioma

July 15, 2026

2148 MRD Study reaches milestone with First Patient In (FPI)

August 4, 2025

IMMUcan has completed patient enrolment

October 31, 2024

Happy 2 year anniversary BioRadon!

October 5, 2023

IMMUcan reaches 1500 Patients enrolled

June 2, 2023

300 Patients Registered for the Bioradon Study

April 26, 2023

2000 Patients Enrolled on the SPECTA Platform

January 9, 2023

Arcagen project recruitment is now complete

October 26, 2022

EORTC and Alliance Healthcare’s continued partnership

May 19, 2022

SEARCH OUR NEWSPROJECTS

Publications

Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterations

Adolescent and young adult (AYA) high grade gliomas (HGG) have... (European Journal of Cancer – 2025)

Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST Project

Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-Invasive... (European Urology Oncology - 2025)

European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’

SPECTAcolor was the first pan-European screening platform for screening CRC patients ... (ESMO Gastrointestinal Oncology - 2025)

EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers

Arcagen (NCT02834884) is a European prospective study aiming at defining the molecular... (npj Precision Oncology - 2024)

Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study

Adolescent and young adult (AYA)... (European Journal of Cancer - 2022)

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study

Despite ongoing challenges for reimbursement in many countries, molecular profiling is... (Annals of Oncology - 2022)

Molecular characterization of Ovarian Yolk Sac Tumor (OYST)

Most patients with malignant ovarian germ cell tumors (MOGTCs) have a very good prognosis and... (Cancers - 2021)

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform

Access to a comprehensive molecular alteration screening... (Scientific Reports - 2022)

Yes IMMUcan! Unraveling the human TME

The great successes achieved by cancer immunotherapy cannot... (Immuno-Oncology Insights - 2021)

Rare cancers in Europe - rationale for the Arcagen project

Rare cancers, of wich brain tumors are an example, represent about...(pg43-) (Brain Tumour Magazine: World Edition 2021/2022 - 2021)

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with European reference network EURACAN

Rare cancers are defined by an incidence of <6 out of... (ESMO Open - 2020)

EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe

For most adolescent and young adult (AYA) cancers... (International Journal of Cancer - 2019)

Latest Newsletters

Latest EDITION

Our top recruiters of the past 3 months, with 4 confirmed patients... June 2025

Seventh EDITION

As you might already be aware, an advisory committee comprising... April 2024

Sixth EDITION

Through SPECTA, we have the opportunity to study the... November 2023

FIFTH EDITION

Thanks to this study we were able to improve our knowledge of... December 2022

FOURTH EDITION

Through SPECTA, we are able to offer our patients the opportunity... January 2022

THIRD EDITION

To the best of my knowledge, SPECTA is the unique way to share... January 2021

SECOND EDITION

There is a well-defined trend, in a broad range of malignancies... May 2020

FIRST EDITION

We are happy to promote in our newsletter the effort of our best... December 2019

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_CFML2VYG4T	2 years	This cookie is installed by Google Analytics.
_gat_gtag_UA_220356330_1	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.

Cookie	Duration	Description
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt.innertube::nextId	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requests	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.